Health Advance Inc. (HADV)
USD 0.0
(-14.29%)
USD 0.0
(-14.29%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -47.95 Thousand USD | 82.16% |
| 2023 | -268.8 Thousand USD | -110.85% |
| 2022 | -130.01 Thousand USD | -476.01% |
| 2021 | 16.96 Thousand USD | 0.0% |
| 2016 | -25.13 Thousand USD | 62.79% |
| 2015 | -67.55 Thousand USD | 5.74% |
| 2014 | -71.66 Thousand USD | 15.99% |
| 2013 | -91.02 Thousand USD | 21.93% |
| 2012 | -109.21 Thousand USD | -61.56% |
| 2011 | -67.63 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 FY | - USD | 82.14% |
| 2024 Q3 | -10.94 Thousand USD | 0.22% |
| 2024 Q2 | -11.01 Thousand USD | 28.27% |
| 2024 Q1 | -15.35 Thousand USD | -46.0% |
| 2023 Q3 | -20.44 Thousand USD | 84.9% |
| 2023 Q4 | -10.27 Thousand USD | 49.76% |
| 2023 Q2 | -135.36 Thousand USD | -416.25% |
| 2023 FY | - USD | -110.85% |
| 2023 Q1 | -26.22 Thousand USD | 0.0% |
| 2022 FY | - USD | -476.01% |
| 2022 Q4 | -26.22 Thousand USD | 0.0% |
| 2021 FY | - USD | 0.0% |
| 2017 Q1 | -9460.00 USD | 14.91% |
| 2017 Q3 | -59.28 Thousand USD | 0.0% |
| 2016 Q1 | -6076.00 USD | 49.83% |
| 2016 Q3 | -6769.00 USD | -38.74% |
| 2016 Q2 | -4879.00 USD | 19.7% |
| 2016 FY | - USD | 62.79% |
| 2016 Q4 | -11.11 Thousand USD | -64.23% |
| 2015 FY | - USD | 5.74% |
| 2015 Q4 | -12.11 Thousand USD | -88.19% |
| 2015 Q3 | -6436.00 USD | -0.91% |
| 2015 Q2 | -6378.00 USD | 60.58% |
| 2015 Q1 | -16.17 Thousand USD | 22.76% |
| 2014 Q2 | -19.04 Thousand USD | -11.56% |
| 2014 Q1 | -17.07 Thousand USD | -3.26% |
| 2014 Q4 | -20.94 Thousand USD | 11.05% |
| 2014 FY | - USD | 15.99% |
| 2014 Q3 | -23.54 Thousand USD | -23.63% |
| 2013 Q3 | -19.01 Thousand USD | 18.12% |
| 2013 Q2 | -23.21 Thousand USD | 34.31% |
| 2013 Q1 | -35.34 Thousand USD | -0.47% |
| 2013 FY | - USD | 21.93% |
| 2013 Q4 | -16.53 Thousand USD | 13.03% |
| 2012 FY | - USD | -61.56% |
| 2012 Q2 | -28.72 Thousand USD | -45.95% |
| 2012 Q1 | -19.68 Thousand USD | 42.48% |
| 2012 Q4 | -35.17 Thousand USD | -216.78% |
| 2012 Q3 | -11.1 Thousand USD | 61.34% |
| 2011 FY | - USD | 0.0% |
| 2011 Q3 | -26.64 Thousand USD | 0.0% |
| 2011 Q4 | -34.21 Thousand USD | -28.42% |
| 2010 Q4 | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | -251.11 USD | -18998.403% |
| Allstar Health Brands, Inc. | -241.78 Thousand USD | 80.165% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 89.4 Million USD | 100.054% |
| Café Serendipity Holdings, Inc. | -1.41 Million USD | 96.611% |
| Decision Diagnostics Corp. | - USD | Infinity% |
| HealthWarehouse.com, Inc. | -1.27 Million USD | 96.239% |
| LIGAND PHARMACEUTICAL INC | 47.23 Million USD | 100.102% |
| MedGen, Inc. | -15.37 USD | -311923.422% |
| Omni Health, Inc. | 1.28 Million USD | 103.725% |
| Oxford Investments Holdings Inc. | -343.96 Thousand USD | 86.057% |
| Pineapple, Inc. | -1.47 Million USD | 96.749% |
| ScripsAmerica, Inc. | -3.95 Million USD | 98.787% |